Showing results (21-30 of 30) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 30 results.
International Journal of Radiation Oncology, Biology, Physics|September 19, 2006
Phase I trial of cetuximab in combination with capecitabine, weekly irinotecan, and radiotherapy as neoadjuvant therapy for rectal cancerRalf-Dieter Hofheinz, Karoline Horisberger, Christoph Woernle, et al.
Plos One|May 27, 2015
Amplicon sequencing of colorectal cancer: variant calling in frozen and formalin-fixed samplesJohannes Betge, Grainne Kerr, Thilo Miersch, et al.
BMC Cancer|August 23, 2011
Expression of Transketolase like gene 1 (TKTL1) predicts disease-free survival in patients with locally advanced rectal cancer receiving neoadjuvant chemoradiotherapyJuliana Schwaab, Karoline Horisberger, Philipp Ströbel, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 4, 2018
Dynamics of Genome Alterations in Crohn's Disease-Associated Colorectal CarcinogenesisDaniela Hirsch, Darawalee Wangsa, Yuelin J Zhu, et al.
International Journal of Radiation Oncology, Biology, Physics|November 26, 2008
mRNA expression of platelet-derived growth factor receptor-beta and C-KIT: correlation with pathologic response to cetuximab-based chemoradiotherapy in patients with rectal cancerPhilipp Erben, Karoline Horisberger, Benjamin Muessle, et al.
International Journal of Radiation Oncology, Biology, Physics|January 10, 2009
Cetuximab in combination with capecitabine, irinotecan, and radiotherapy for patients with locally advanced rectal cancer: results of a Phase II MARGIT trialKaroline Horisberger, Anne Treschl, Sabine Mai, et al.
Hereditary Cancer in Clinical Practice|May 13, 2024
Incidences of colorectal adenomas and cancers under colonoscopy surveillance suggest an accelerated "Big Bang" pathway to CRC in three of the four Lynch syndromesPål Møller, Saskia Haupt, Aysel Ahadova, et al.
Hereditary Cancer in Clinical Practice|October 11, 2023
Dominantly inherited micro-satellite instable cancer - the four Lynch syndromes - an EHTG, PLSD position statementPal Møller, Toni T Seppälä, Aysel Ahadova, et al.
Eclinicalmedicine|May 14, 2023
Mortality by age, gene and gender in carriers of pathogenic mismatch repair gene variants receiving surveillance for early cancer diagnosis and treatment: a report from the prospective Lynch syndrome databaseMev Dominguez-Valentin, Saskia Haupt, Toni T Seppälä, et al.
Hereditary Cancer in Clinical Practice|October 1, 2022
Colorectal cancer incidences in Lynch syndrome: a comparison of results from the prospective lynch syndrome database and the international mismatch repair consortiumPål Møller, Toni Seppälä, James G Dowty, et al.
Pageof 3